Reading this on a mobile device? Try our optimized mobile version here:

April 24, 2012News for the transfusion medicine and cellular therapy community

  Top Story 
  • "Priceless" serum collection advances understanding of disease
    The U.S. government has taken charge of the Warren Serum Collection, which includes 40,000 tubes of blood serum. The blood samples were collected from 9,000 airmen from 1948 to 1954 for rheumatic fever research. Samples from the collection have been used to study hepatitis C and celiac disease, and it is one of many biological repositories that are becoming increasingly valuable as research tools. The Washington Post (4/23) LinkedInFacebookTwitterEmail this Story
Now FDA Approved! Quotient Reagent Red Blood Cells
Samples of Quotient Biodiagnostics' full range of ALBAcyte® Reagent Red Blood Cell products are now available. To try this new alternative, contact us today to receive reverse, antibody screening and antibody identification cells. See the difference in our customer care and superior value as you sample our products. Contact your rep or 888.284.1901.

  Science & Health 
  • Protein regulates conversion of stem cells into fat, bone tissue
    Reducing the amount of endoglin protein on the surface of stem cells curbs the production of fat cells and spurs the growth of bone tissue, according to a study presented at the American Society for Biochemistry and Molecular Biology's annual meeting. Research on osteoporosis led to the discovery, which could have applications in treatments for obesity, researchers said. (4/23) LinkedInFacebookTwitterEmail this Story
  • Coating for joint implants stimulates stem cells
    Chemical engineers at MIT have created a coating that attracts mesenchymal stem cells to stimulate the production of bone and improve the way joint implants attach, reducing the risk of infection or failure. The coating, made of a thin film measuring from 100 nanometers to one micron, draws the cells from bone marrow. The work was reported in the journal Advanced Materials. Mass High Tech (Boston) (4/19) LinkedInFacebookTwitterEmail this Story
  • U.S. clears publication of bird flu transmission studies
    HHS Secretary Kathleen Sebelius and National Institutes of Health Director Dr. Francis Collins announced the U.S. government has decided to allow the publication of bird flu research involving the creation of a strain that is easily transmissible among ferrets. "This information has clear value to national and international public health preparedness efforts and must be shared," Collins said. Bloomberg (4/20) LinkedInFacebookTwitterEmail this Story
  • Combination treatment to be introduced on World Malaria Day
    Ranbaxy Laboratories and India's health ministry will introduce a synthetic malaria treatment that combines arterolane and piperaquine. The drug, administered once daily for three days, could be an alternative to the plant-based medication artemisinin. The launch is planned for Wednesday, which is World Malaria Day. The Times of India (4/24) LinkedInFacebookTwitterEmail this Story
Blood Component Preparation: From Benchtop to Bedside
This book offers the broad perspective needed for understanding current methods of blood component preparation. Wide-ranging topics go beyond the laboratory while complementing other procedure-based methods manuals. Discussing specific processes, rationale, published experience, and research; click here to order.

  Industry News & Practice 
  Government & Regulatory 
  • Health IT panel addresses clinical quality measures in stage 2 MU
    A Health Information Technology Policy Committee work group met Monday to discuss how best to integrate clinical quality measures in the second stage of meaningful use criteria for electronic health records. One option would allow eligible providers to choose 12 out of 125 proposed measures, with at least one standard addressing each of six domains for care improvement. The group will meet again Friday before submitting its final thoughts to the full committee May 4. Modern Healthcare (subscription required) (4/23) LinkedInFacebookTwitterEmail this Story
  Association News 
  • AABB audioconference will highlight autologous blood management
    The AABB audioconference on Wednesday, April 25, will feature a discussion of the advantages and disadvantages of autologous blood compared to banked blood, expected economic outcomes of an autologous blood program, as well as guidance on how to develop and implement an autologous blood program. The audioconference also will highlight ways to encourage participation by both clinicians and administrators. Sign up here. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Country Director - MozambiqueAABBMOZ - Nationwide
Senior Project ManagerBlood Systems, Inc.US - AZ - Scottsdale
Transfusion Safety CoordinatorPacific Diagnostic Laboratories, LLCUS - CA - Santa Barbara
Standards Development SpecialistAABBUS - MD - Bethesda
(CEO), Greater Ozarks RegionAmerican Red CrossUS - AR - Little Rock
Deputy Director, Regulatory Affairs - Cellular TherapyAABBUS - MD - Bethesda
Click here to view more job listings.

There are three cures for ennui: sleep, drink and travel."
--D.H. Lawrence,
British novelist

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format | Web version | Search past news | Archive | Privacy policy

Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
A powerful website for SmartBrief readers including:
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor:  Aaron Lyss
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.® Legal Information